832 research outputs found
Libby Scheier, Sarah Sheard, and Eleanor Wachtel, eds. Language in Her Eye: Views on Writing and Gender by Canadian Women Writing in English
Air-flow Behavior over the Wing of an XP-51 Airplane as Indicated by Wing-surface Tufts at Subcritical and Supercritical Speeds
Intersubband transitions in nonpolar GaN/Al(Ga)N heterostructures in the short and mid-wavelength infrared regions
This paper assesses nonpolar m- and a-plane GaN/Al(Ga)N multi-quantum-wells
grown on bulk GaN for intersubband optoelectronics in the short- and
mid-wavelength infrared ranges. The characterization results are compared to
those for reference samples grown on the polar c-plane, and are verified by
self-consistent Schr\"odinger-Poisson calculations. The best results in terms
of mosaicity, surface roughness, photoluminescence linewidth and intensity, as
well as intersubband absorption are obtained from m-plane structures, which
display room-temperature intersubband absorption in the range from 1.5 to 2.9
um. Based on these results, a series of m-plane GaN/AlGaN multi-quantum-wells
were designed to determine the accessible spectral range in the mid-infrared.
These samples exhibit tunable room-temperature intersubband absorption from 4.0
to 5.8 um, the long-wavelength limit being set by the absorption associated
with the second order of the Reststrahlen band in the GaN substrates
Keck Echellette Spectrograph and Imager Observations of Metal-poor Damped Lyα Systems
We present the first results from a survey of SDSS quasars selected for strong H I damped Lyα (DLA) absorption with corresponding low equivalent width absorption from strong low-ion transitions (e.g., C II λ1334 and Si II λ1260). These metal-poor DLA candidates were selected from the SDSS fifth release quasar spectroscopic database, and comprise a large new sample for probing low-metallicity galaxies. Medium-resolution echellette spectra from the Keck Echellette Spectrograph and Imager spectrograph for an initial sample of 35 systems were obtained to explore the metal-poor tail of the DLA distribution and to investigate the nucleosynthetic patterns at these metallicities. We have estimated saturation corrections for the moderately underresolved spectra, and systems with very narrow Doppler parameters (b ≤ 5 km s^(–1)) will likely have underestimated abundances. For those systems with Doppler parameters b > 5 km s^(–1), we have measured low-metallicity DLA gas with [X/H] < –2.4 for at least one of C, O, Si, or Fe. Assuming non-saturated components, we estimate that several DLA systems have [X/H] < –2.8, including five DLA systems with both low equivalent widths and low metallicity in transitions of both C II and O I. All of the measured DLA metallicities, however, exceed or are consistent with a metallicity of at least 1/1000 of solar, regardless of the effects of saturation in our spectra. Our results indicate that the metal-poor tail of galaxies at z ~ 3 drops exponentially at [X/H] ≾ –3. If the distribution of metallicity is Gaussian, the probability of identifying interstellar medium gas with lower abundance is extremely small, and our results suggest that DLA systems with [X/H] < –4.0 are extremely rare, and could comprise only 8 × 10^(–7) of DLA systems. The relative abundances of species within these low-metallicity DLA systems are compared with stellar nucleosynthesis models, and are consistent with stars having masses of 30 M_⊙ < M * < 100 M_⊙. The observed ratio of [C/O] for values of [O/H] < –2.5 exceeds values seen in moderate metallicity DLA systems, and also exceeds theoretical nucleosynthesis predictions for higher mass Population III stars. We also have observed a correlation between the column density N(C IV) with [Si/H] metallicity, suggestive of a trend between mass of the DLA system and its metallicity
Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate
INTRODUCTION
Adverse drug reactions (ADRs) contribute to morbidity, and serious ADRs may cause hospitalisation and death. This study characterises and quantifies ADR-related hospitalisations and subsequent in-hospital deaths, and estimates the spontaneous reporting rate to regulatory authorities in Switzerland, where healthcare professionals are legally obliged to report ADRs.
METHODS
This retrospective cohort study from 2012 to 2019 analysed nationwide data from the Federal Statistical Office. ICD-10 coding rules identified ADR-related hospitalisations. To estimate the reporting rate, individual case safety reports (ICSRs) collected in the Swiss spontaneous reporting system during the same period were considered.
RESULTS
Among 11,240,562 inpatients, 256,550 (2.3%) were admitted for ADRs, 132,320 (51.6%) were female, 120,405 (46.9%) were aged ≥ 65 (median of three comorbidities, interquartile range [IQR] 2-4), and 16,754 (6.5%) were children/teenagers (0 comorbidities, IQR 0-1). Frequent comorbidities were hypertension (89,938 [35.1%]), fluid/electrolyte disorders (54,447 [21.2%]), renal failure (45,866 [17.9%]), cardiac arrhythmias (37,906 [14.8%]), and depression (35,759 [13.9%]). Physicians initiated 113,028 (44.1%) of hospital referrals, and patients/relatives 73,494 (28.6%). Frequently ADR-affected were the digestive system (48,219 [18.8%], e.g. noninfective gastroenteritis and colitis), the genitourinary system (39,727 [15.5%], e.g. acute renal failure), and the mental/behavioural state (39,578 [15.4%], e.g. opioid dependence). In-hospital mortality was 2.2% (5669). Since ICSRs indicated 14,109 hospitalisations and 700 in-hospital deaths, estimated reporting rates were 5% and 12%, respectively.
CONCLUSIONS
This 8-year observation in Switzerland revealed that 2.3%, or roughly 32,000 admissions per year, were caused by ADRs. The majority of ADR-related admissions were not reported to the regulatory authorities, despite legal obligations
Measurements of the Wing and Tail Loads During the Acceptance Tests of Bell XS-1 Research Airplane
Number of Common Sites Visited by N Random Walkers
We compute analytically the mean number of common sites, W_N(t), visited by N
independent random walkers each of length t and all starting at the origin at
t=0 in d dimensions. We show that in the (N-d) plane, there are three distinct
regimes for the asymptotic large t growth of W_N(t). These three regimes are
separated by two critical lines d=2 and d=d_c(N)=2N/(N-1) in the (N-d) plane.
For d<2, W_N(t)\sim t^{d/2} for large t (the N dependence is only in the
prefactor). For 2<d<d_c(N), W_N(t)\sim t^{\nu} where the exponent \nu=
N-d(N-1)/2 varies with N and d. For d>d_c(N), W_N(t) approaches a constant as
t\to \infty. Exactly at the critical dimensions there are logaritmic
corrections: for d=2, we get W_N(t)\sim t/[\ln t]^N, while for d=d_c(N),
W_N(t)\sim \ln t for large t. Our analytical predictions are verified in
numerical simulations.Comment: 5 pages, 3 .eps figures include
Adiabaticity and localization in one-dimensional incommensurate lattices
We experimentally investigate the role of localization on the adiabaticity of
loading a Bose-Einstein condensate into a one-dimensional optical potential
comprised of a shallow primary lattice plus one or two perturbing lattice(s) of
incommensurate period. We find that even a very weak perturbation causes
dramatic changes in the momentum distribution and makes adiabatic loading of
the combined lattice much more difficult than for a single period lattice. We
interpret our results using a band structure model and the one-dimensional
Gross-Pitaevskii equation.Comment: 4 pages, 3 figures; v2: figures improved (particularly fig 3), some
refs. added, clarifications in discussion, fixed typo
Frequency-based rare diagnoses as a novel and accessible approach for studying rare diseases in large datasets: a cross-sectional study
BACKGROUND
Up to 8% of the general population have a rare disease, however, for lack of ICD-10 codes for many rare diseases, this population cannot be generically identified in large medical datasets. We aimed to explore frequency-based rare diagnoses (FB-RDx) as a novel method exploring rare diseases by comparing characteristics and outcomes of inpatient populations with FB-RDx to those with rare diseases based on a previously published reference list.
METHODS
Retrospective, cross-sectional, nationwide, multicenter study including 830,114 adult inpatients. We used the national inpatient cohort dataset of the year 2018 provided by the Swiss Federal Statistical Office, which routinely collects data from all inpatients treated in any Swiss hospital. Exposure: FB-RDx, according to 10% of inpatients with the least frequent diagnoses (i.e.1.decile) vs. those with more frequent diagnoses (deciles 2-10). Results were compared to patients having 1 of 628 ICD-10 coded rare diseases.
PRIMARY OUTCOME
In-hospital death.
SECONDARY OUTCOMES
30-day readmission, admission to intensive care unit (ICU), length of stay, and ICU length of stay. Multivariable regression analyzed associations of FB-RDx and rare diseases with these outcomes.
RESULTS
464,968 (56%) of patients were female, median age was 59 years (IQR: 40-74). Compared with patients in deciles 2-10, patients in the 1. were at increased risk of in-hospital death (OR 1.44; 95% CI: 1.38, 1.50), 30-day readmission (OR 1.29; 95% CI 1.25, 1.34), ICU admission (OR 1.50; 95% CI 1.46, 1.54), increased length of stay (Exp(B) 1.03; 95% CI 1.03, 1.04) and ICU length of stay (1.15; 95% CI 1.12, 1.18). ICD-10 based rare diseases groups showed similar results: in-hospital death (OR 1.82; 95% CI 1.75, 1.89), 30-day readmission (OR 1.37; 95% CI 1.32, 1.42), ICU admission (OR 1.40; 95% CI 1.36, 1.44) and increased length of stay (OR 1.07; 95% CI 1.07, 1.08) and ICU length of stay (OR 1.19; 95% CI 1.16, 1.22).
CONCLUSION(S)
This study suggests that FB-RDx may not only act as a surrogate for rare diseases but may also help to identify patients with rare disease more comprehensively. FB-RDx associate with in-hospital death, 30-day readmission, intensive care unit admission, and increased length of stay and intensive care unit length of stay, as has been reported for rare diseases
- …